探索量化價值
訂閱我們的電子報,獲取尖端的量化策略和見解。


Factor premiums can be found in stock markets across the world, including emerging markets. But does factor allocation in emerging markets really add value to a global equity portfolio in practice? The short answer, we argue, is yes.
In a recent research note, we investigated whether allocating part of an investor’s portfolio to emerging markets equities adds value to a global equity portfolio. Using market data over the period from January 1988 to December 2017, we investigated whether investors should allocate to emerging stocks and how they should go about it.
More specifically, we considered two main options. The first is based on a passive allocation that replicates the MSCI Emerging Markets Total Return Index. The second involves allocation to the well-known value and momentum factors, within the MSCI Emerging Markets Total Return Index investment universe, using a ranking approach, as well as relatively simple factor definitions and portfolio construction rules (investing in the 33% most attractive stocks from a factor perspective, with monthly rebalancing).
The gains of allocating to EM are far greater when value and momentum are taken into account
訂閱我們的電子報,獲取尖端的量化策略和見解。
We found that, historically, allocating part of an investor’s portfolio to passive emerging markets equities increased the portfolio’s risk-adjusted return. However, the gains of allocating to emerging markets are far greater when value and momentum factors are taken into account in the stock selection process. The benefits of allocating to factors in emerging markets can be significant, even when factor investing is already implemented in the developed markets part of the portfolio.
In our analysis, we also considered more sophisticated portfolio construction rules that do not entail the immediate sale of stocks that become less attractive in terms of factor exposure. Instead, every quarter, only stocks that are no longer among the top 50% are sold. These stocks are then replaced by the most attractive stocks at that time not yet included in the portfolio. Our calculations showed that compared to a more static approach, this dynamic approach leads to both lower turnover and higher returns.
Based on prudent assumptions, we also looked at the impact of transaction costs and management fees on performance. More specifically, we assumed trading costs of 30 basis points for developed markets stocks and 50 basis points for emerging markets stocks. We also assumed annualized management fees of 10 basis points for passive developed markets, and 20 basis points for passive emerging markets. An additional 10 basis points per annum mark-up was included for the factor portfolios. Our conclusion is that even once these costs have been incorporated, allocating to emerging markets factor premiums still adds substantial value.
Finally, we analyzed the performance of the different investment strategies over two equal sub-periods: from January 1988 until the end of 2002 and from 2003 until December 2017. The results in both sample periods were in line with the findings for the overall sample. Allocating to emerging markets improved the Sharpe ratio of the portfolio in both sub-periods, and allocating to the value and momentum factors further improved the Sharpe ratios.
As result, we advise investors to allocate part of their portfolio to factor premiums in emerging equity markets, all the more so given that the factor definitions used in our study are relatively simple. We argue that efficient factor investing strategies using enhanced factor definitions, as well as smart rules for stock selection and portfolio construction, can achieve even better investment results, while lowering both risks and costs.
Robeco has been successfully running factor-based portfolios in emerging markets for over ten years now. Since its launch in 2008, our Active Equities strategy has proven its ability to consistently and significantly outperform the MSCI Emerging Markets Index, both in up and down markets, delivering positive excess returns in eight out of nine full calendar years.
本網站僅供《證券及期貨條例》(香港法例第571章)及其附屬法例所界定之專業投資者瀏覽及使用。 投資涉及風險。過往表現並不代表未來表現。本網站所載資料僅供參考之用,並不構成任何投資建議,亦非作出買賣任何證券或採納任何投資策略之要約或招攬。投資者不應僅憑本網站提供之資料作出投資決定,在作出任何投資決定前,應徵詢獨立意見(包括有關稅務影響之意見)。投資者應確保完全理解投資產品的相關風險,亦應考量自身投資目標及風險承受水平。投資乃閣下之個人決定。除非銷售投資產品的中介人已向閣下告知該投資產品適合閣下,並已解釋其符合閣下投資目標之原因,否則閣下不應投資。請參閱相關發售文件或其他法律文件,以獲取包括風險因素在內的進一步詳情。 本網站由荷寶投資管理香港有限公司發布,該公司受香港證券及期貨事務監察委員會(「證監會」)規管(中央編號:APU851)。本網站未經證監會審閱。 無法保證任何投資產品可實現其投資目標。概不就任何投資產品之表現或投資回報作任何聲明或承諾。投資的價值或會波動。本網站所載過往表現、推算或預測,均不應視作未來表現之保證或指標,且概不提供任何明示或暗示之保證。本網站內容建基於相信為可靠之來源,惟因應資料傳遞技術特性及須採用多項數據來源(包括第三方內容),故概不保證其準確性。所述觀點僅乃截至上述日期,或會隨市況變化而改變,可予更改而毋須另行通知。該等意見可能有別於其他荷寶投資專業人士之意見。因使用本材料或當中所載任何評論、意見或估算而引致之直接、間接或相應損失,荷寶概不承擔法律責任。荷寶並無責任更新本網站或任何網站內容。未經荷寶事先書面許可,不得複製、分發或刊發本網站任何材料。 除非另有說明,資料來源:荷寶。